IFNA1 and cancer: For example, ligating intracellular TLR (3, 7, 8, or 9) could force DCs and macrophages to increase the production of IFN-α, IL-6, IL-8, IL-12, and TNF-α, thus enhancing Th1 cell-mediated anti-cancer immune responses [20,21].